Some are, but with limitations: Liraglutide (Saxenda) is approved for weight management in adolescents aged 12-17 with obesity and a body weight above 132 pounds
Spotlight on Key Peptides The world of peptides is vast, but a few candidates are making headlines for autoimmune conditions
With Klinic's online platform, there's no need for an in-person visit
The Significance of Lifestyle Changes Diet and Nutrition While semaglutide can aid in appetite suppression, it is not a replacement for a healthy diet
With the new deal, Medicare will no longer only cover these drugs for diabetes or heart issues, but for obesity itself, potentially saving beneficiaries hundreds of dollars each month
Phase 2 data published in 2023 reported mean body-weight reductions of up to 24.2% at 48 weeks on the highest dose tier (Jastreboff et al., NEJM 2023)